Alterity Therapeutics (ATHE) Current Taxes (2022 - 2025)
Alterity Therapeutics (ATHE) recorded quarterly Current Taxes of $10460.6 in Q4 2025, little changed quarter-over-quarter from $10426.3 in Q2 2025, and down 6.74% on a YoY basis from $11216.7 in Q4 2024.
Alterity Therapeutics (ATHE) Current Taxes (2022 - 2025) Analysis & Trends
Alterity Therapeutics' Current Taxes history runs 4 years deep, the most recent figure standing at $10460.6 for Q4 2025.
- In Q4 2025, Current Taxes fell 6.74% year-over-year to $10460.6; the TTM figure through Dec 2025 stood at $10460.6 (down 6.74% YoY), while the FY2025 annual figure was $10426.3, up 6418.44% from the prior year.
- Current Taxes was $10460.6 for Q4 2025 at Alterity Therapeutics, roughly flat from $10426.3 in the prior quarter.
- In the past five years, Current Taxes ranged from a high of $19284.8 in Q2 2022 to a low of $10426.3 in Q2 2025.
- Historically, Current Taxes has averaged $14516.9 across 4 years, with a median of $14437.7 in 2023.
- The sharpest annual moves came in 2024 and 2025: Current Taxes sank 43.53% in 2024, then retreated 1.09% in 2025.
- A 4-year view of Current Taxes shows it stood at $17879.5 in 2022, then declined by 1.23% to $17658.8 in 2023, then sank by 36.48% to $11216.7 in 2024, then dropped by 6.74% to $10460.6 in 2025.
- The last three Current Taxes figures came in at $10460.6 (Q4 2025), $10426.3 (Q2 2025), and $11216.7 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 10,460.56 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 19.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 10,460.56 |
| Jun 30, 2025 | 10,426.25 |
| Dec 31, 2024 | 11,216.66 |
| Jun 30, 2024 | 10,541.10 |
| Dec 31, 2023 | 17,658.77 |
| Jun 30, 2023 | 18,667.31 |
| Dec 31, 2022 | 17,879.53 |
| Jun 30, 2022 | 19,284.81 |